Pasithea Therapeutics Corp. Share Price

Pasithea Therapeutics Corp. Share Price

NASDAQ: KTTA | Micro Cap
$0.36
-$0.00 (-0.63%) Last updated on 31 Oct, 2026 | 00:41 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pasithea Therapeutics Corp. Stock Performance

Open
$0.37
Prev. Close
$0.37
Circuit Range
N/A
Day Range
$0.37 - $0.38
Year Range
$0.29 - $2.06
Volume
8,736
Average Traded
$0.38

Pasithea Therapeutics Corp. Share Price Today

As of 31 October 2026, Pasithea Therapeutics Corp.'s share price is $0.36. The stock opened at $0.37, compared to its previous close of $0.37. During today's trading session, Pasithea Therapeutics Corp.'s share price traded between $0.37 and $0.38, with an average price of $0.37. Over the past 52 weeks, the stock has recorded a high of $2.06 and a low of $0.29. In terms of performance, Pasithea Therapeutics Corp.'s share price has declined by 48.31% over the last six months and is down 54.44% on a year-on-year basis.

Pasithea Therapeutics Corp. Share Price Chart

Line chart of the Pasithea Therapeutics Corp. price trend over the selected period. The price fell overall, ranging from 0.36 to 0.38, ending at 0.36.
$0.37$0.38
L
Show Current Price
H

Pasithea Therapeutics Corp. Stock Fundamentals & Key Indicators

Market Cap
$2.57M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$0.00
Return On Equity (TTM)
-42.72%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-73.36%

Pasithea Therapeutics Corp. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.04-$10.11-$2.87-$5.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-232.57%71.61%-83.62%

Pasithea Therapeutics Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.94-$15.96-$13.90-$20.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.49%12.91%-46.98%

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Pasithea Therapeutics Corp. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.46
$0.38
-23.08%
Sep 2026
$0.55
$0.49
-10.99%
Aug 2026
$0.45
$0.56
+19.35%
Jul 2026
$0.59
$0.47
-9.36%
Jun 2026
$0.71
$0.51
-27.85%
May 2026
$0.72
$0.71
+0.71%
Apr 2026
$0.65
$0.71
-5.87%
Mar 2026
$0.83
$0.75
-8.42%
Feb 2026
$0.85
$0.82
-4.99%
Jan 2026
$1.23
$0.86
-33.69%
Dec 2025
$1.25
$1.30
-10.96%
Nov 2025
$0.82
$1.46
+82.27%

KTTA Share Price FAQs